High productivity: key to survive under new FTA conditions.

Published: 2007-05-01 07:00:00

Updated: 2007-05-01 07:00:00

Samsung economic research institute (SERI) predicted that to survive under the KORUS FTA conditions the pharmaceutical industry should be transformed by a proactive leadership of the generic drug company with high productivity.

SERI published a report on April 25 titled "KORUS FTA and opportun...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK